[79] In contrast, no differences in blood pressure were noted in a small study that compared pharmacists with an education control.[77] However, results may have been influenced by study limitations related to low patient enrollment. Statistically significant improvements in both medication adherence and medication use with pharmacist-led interventions were reported in the SR by Greer et al. (2016).[75] The barbershop study by Victor et al. (2018) showed an increase in the number of blood pressure medications per participant.[80] Improved adherence in favor of a pharmacist-led intervention was shown in one study conducted in Pakistan in which the intervention involved education.[81] There was also some evidence of improved medication use (in terms of either the numbers of antihypertensive medications used or adherence) in the referenced studies. The Work Group determined that, in addition to providing education, there was a significant role for pharmacists in actively titrating antihypertensive drugs and managing AEs. This conclusion was based on findings from two SRs of RCTs in which pharmacists performed these higher level interventions.[75,76] Ensuring pharmacists are appropriately qualified to provide these services is also important. The study conducted by Cheema et al. (2018) utilized community pharmacists.[78] However, in both the VA and DoD, this recommendation is intended for pharmacists in the clinic setting, and not dispensing pharmacists. Some variation was noted in patient values and preferences. The patient focus group did not discuss pharmacist-led interventions; however, in the evidence base, patients enjoyed the flexibility and ease of access to pharmacists and appreciated the improved access to care.[75,80] The benefits of pharmacist- led care outweighed the harms due to the low number of adverse events reported with the interventions in the barbershop trial.[80] The SR by Greer et al. 